Results 81 to 90 of about 49,863 (128)

BRAF inhibitor-induced necrotizing granulomatous lymphadenopathy: a case report of drug-induced sarcoid-like reaction. [PDF]

Proc (Bayl Univ Med Cent)
Firouzbakht S, Rizvi A, Mosher A, Yaqub S, Sigler M.   +4 more
europepmc   +1 more source

Response to dabrafenib and trametinib combined with pembrolizumab in an elderly patient with lung adenocarcinoma of unknown primary harboring BRAF V600E mutation and high PD-L1 expression: a case report. [PDF]

Front Immunol
Li N, Hu J, Bao G, Cai Z.
europepmc   +1 more source

The Potential of Phytochemicals to Overcome Multidrug Resistance in Metastatic Melanoma. [PDF]

Chem Biodivers
Maphutha J, Twilley D, Dawood M, Efferth T, Efferth T, Lall N.   +5 more
europepmc   +1 more source

Diagnostic Challenges in Sessile Serrated Lesions: Progression to Adenocarcinoma in a High-Risk Patient. [PDF]

Am J Case Rep
Ahmed S, Kaur H, Diab MO, Nadir A.
europepmc   +1 more source

Characterization and inhibitor sensitivity of ARAF, BRAF, and CRAF kinases. [PDF]

J Biol Chem
Tkacik E, Jang DM, Boxer K, Ha BH, Eck MJ.   +4 more
europepmc   +1 more source

DA-Raf synergistically binds to the plasma membrane and Ras to suppress ERK signaling. [PDF]

Life Sci Alliance
Takano K, Tsujita K, Suganami A, Nakamura T, Kanno E, Tamura Y, Itoh T, Endo T.   +7 more
europepmc   +1 more source

Clinical Significance and Potential Molecular Mechanisms of Angiotensin-Converting Enzyme 2 in Colorectal Cancer. [PDF]

World J Oncol
Zeng DT, Yang L, Wen JY, Wu KJ, Chen GQ, Li ZY, Ling JW, Huang BB, Xie YY, Dong YY, Fang YY, Wei DM, Chen G, Shi L, Huang WJ.   +14 more
europepmc   +1 more source

SCAMP3-Driven Regulation of ERK1/2 and Autophagy Phosphoproteomics Signatures in Triple-Negative Breast Cancer. [PDF]

Int J Mol Sci
Morales-Cabán BM, Cantres-Rosario YM, Tosado-Rodríguez EL, Roche-Lima A, Meléndez LM, Boukli NM, Suarez-Arroyo IJ.   +6 more
europepmc   +1 more source

EC359 Enhances Trametinib Efficacy in <i>Ras</i>/<i>Raf</i>-Driven Ovarian Cancer by Suppressing LIFR Signaling. [PDF]

Biomolecules
Arnold WC, Panneerdoss DM, Subramani B, Mahajan M, Ebrahimi B, Ramirez P, Santhamma B, Viswanadhapalli S, Kost ER, Chen Y, Lai Z, Nair HB, Vadlamudi RK, Lyons YA.   +13 more
europepmc   +1 more source

Targeting BRAF in cancers - from molecular diagnostics to personalized therapy. [PDF]

BioTechnologia (Pozn)
Pyc Z, Rygiel R, Michalowska D, Ekiert M, Laczmanska I.   +4 more
europepmc   +1 more source